XM does not provide services to residents of the United States of America.
M
M

Mercialys

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Bureau Veritas, Covestro AG, Redcare Pharmacy NV

EUROPE RESEARCH ROUNDUP-Bureau Veritas, Covestro AG, Redcare Pharmacy NV Oct 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bureau Veritas, Covestro AG and Redcare Pharmacy NV, on Wednesday. HIGHLIGHTS * British Land BLND.L : Deutsche Bank raises to buy from hold * Bureau Veritas BVI.PA : JP Morgan cuts to neutral from overweight * Covestro AG 1COV.DE : Jefferies cuts to hold from buy * Redcare Pharmacy NV RDC.DE : HSBC raises t
A
A
A
B
B
B
D
E
E
E
E
E
E
E
F
G
I
M
M
A
A
A
A
B
B
E
G
Z

Jefferies cuts Mercialys to 'hold' amid Casino's woes

BUZZ-Jefferies cuts Mercialys to 'hold' amid Casino's woes ** Jefferies cuts French property management company Mercialys MERY.PA to "hold" from "buy" as supermarket chain Casino CASP.PA will close stores owned by Mercialys ** Out of 19 outlets closing this week, six are located in Mercialys' shopping centres, while two are directly owned by it, ac
C
M

Mercialys Issues Euro 300 Mln Bond With 7-Year Maturity

BRIEF-Mercialys Issues Euro 300 Mln Bond With 7-Year Maturity Sept 3 (Reuters) - Mercialys SA MERY.PA : MERCIALYS SUCCESSFULLY PLACES A EURO 300 MILLION BOND ISSUE WITH A 7-YEAR MATURITY BOND ISSUE WITH 4.0% COUPON, BASED ON A 165 BP SPREAD ISSUE WAS 7.3 TIMES OVERSUBSCRIBED Source text for Workspace: nBw6Lwch3a Further company coverage: MERY.PA (G
M

Klepierre rises on 'Robust H1', hikes outlook

BUZZ-Klepierre rises on 'Robust H1', hikes outlook ** Shares in French shopping centre operator Klepierre LOIM.PA rise 4% after it posted positive H1 results and a 2% increase in EPS guidance ** "In many aspects, we see this set of results as better than peers," says Jefferies, adding that company's LFL growth is up 6% vs 3.4% to 5.3% growth reported by its peers, including URW, Mercialys and Carmila ** Results were solid despite a challenging retail environment, says Degroof Petercam ** "The st
K
M

Mercialys Confirms 2024 Objectives, H1 EBITDA Up 5.2%

BRIEF-Mercialys Confirms 2024 Objectives, H1 EBITDA Up 5.2% July 24 (Reuters) - Mercialys SA MERY.PA : H1 NET RECURRENT EARNINGS PER SHARE OF EUR 0.63 2024 OBJECTIVES CONFIRMED H1 NET RENTAL INCOME OF EUR 87.4 MILLION H1 EBITDA EUR 76.1 MILLION, UP 5.2% YOY Source text for Workspace: ID:nNDL1mgW3y Further company coverage: MERY.PA (Gdansk Newsroom)
M

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.